Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment

Fanning, Saranna, Haque, Aftabul, Imberdis, Thibaut, Baru, Valeriya, Barrasa, M. Inmaculada, Nuber, Silke, Termine, Daniel, Ramalingam, Nagendran +23 more·2019·Molecular Cell

Cited by (297)

Items 201–297 of 297

  1. Interplay between lipid droplets and alpha-synuclein: implication in Parkinson’s disease pathogenesis
    Walid Idi, Razan Sheta, Abid Oueslati · 2025 · Frontiers in Molecular Neuroscience
  2. Brain lipidomics for region-specific biomarker discovery in neurodegenerative diseases
    Jayashankar Jayaprakash, Solomon Tebeje Gizaw, Divyavani Gowda, Hiroshi Hinou, Nishimura Si, Shu‐Ping Hui, Siddabasave Gowda B. Gowda · 2026 · Frontiers in Aging Neuroscience
  3. Interfering with aggregated α-synuclein in advanced melanoma leads to a major upregulation of MHC class II proteins
    Claudia Fokken, Ivan Silbern, Orr Shomroni, Kuan‐Ting Pan, Sergey Ryazanov, Andrei Leonov, Nadine Winkler, Henning Urlaub, Christian Griesinger, Dorothea Becker · 2024 · Melanoma Research
  4. Mitochondrial Dysfunction in Parkinson’s Disease: Is Impaired Deuterium Depleted Nutrient Supply by Gut Microbes a Primary Factor?
    Stephanie Seneff, Greg Nigh, Anthony M. Kyriakopoulos · 2025 · Biocell
  5. Brain lipidomics identifies mitochondrial redox dysfunction and metabolic trade-offs associated with Parkinson's disease-like pathology induced by Nanoplastics exposure
    Priya Rathor, Ashutosh Tiwari, Rajendra P. Patel, Anoop Kumar Verma, Sheelendra Pratap Singh, Ratnasekhar Ch · 2026 · Free Radical Biology and Medicine
  6. Overexpression of α-synuclein in Pigment Dispersing Factor neurons alters sleep–wake pattern by regulating lipid metabolism in Drosophila
    Dong Xia, Ying Chen, Xiang Fu, Huiyi Liu, Mu-Yan Sun, Fen Wang, Yong Zhang, Chun‐Feng Liu, Junyi Liu · 2024 · SLEEP
  7. A Multimodal Omics Exploration of the Motor and Non-Motor Symptoms of Parkinson’s Disease
    François‐Xavier Lejeune, Farid Ichou, Etienne Camenen, Benoît Colsch, Florence Mauger, Caroline Peltier, Ivan Moszer, Emmanuel Gilson, Morgane Pierre‐Jean, Édith Le Floch et al. · 2022 · International Journal of Translational Medicine
  8. A non-canonical lipid droplet metabolism regulates the conversion of alpha-Synuclein to proteolytic resistant forms in neurons of a Drosophila model of Parkinson disease
    Victor Girard, Florence Jollivet, Oskar L. Knittelfelder, Jean-Noël Arsac, Gilles Chatelain, Daan M. van den Brink, Thierry Baron, Andrej Shevchenko, Nathalie Davoust, Bertrand Mollereau · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  9. α-Synuclein Activates the PI3K/AKT Pathway to Drive Lipid Droplets Accumulation: Implications for Parkinson’s Disease
    Suaad Abd Elhadi, Jenna Congdon-Loeffler, Eva Harrosch, Dima Khatib, Lama Naamneh, Meir Schechter, Alexandra Eliassaf, Ori Shalev, Ronit Sharon · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Lipid Alterations and Pathogenic Roles in Synucleinopathies
    Estela Área-Gómez, Saranna Fanning, Ulf Dettmer · 2025 · Cold Spring Harbor Perspectives in Medicine
  11. Glycerol 3-phosphate acyltransferase exacerbates α-synuclein-induced toxicity by increasing lipid peroxidation
    Mengda Ren, Grace Gui-Yin Lim, Willcyn Tang, Kah‐Leong Lim · 2026 · Nature Communications
  12. Lipid droplets in neurodegenerative diseases: pathological drivers and therapeutic vulnerabilities
    Ourania Papapanagiotou, Kian Cotton, Christopher Edwards, David Michod, Lucy Crompton, Tim J. Craig, Maria Victoria Niklison-Chirou · 2026 · Cell Death Discovery
  13. Small Molecule Improvement of Trafficking Defects in Models of Neurodegeneration
    A. Katherine Hatstat, Michael D. Pupi, Michaela C. Reinhart, Dewey Granville McCafferty · 2021 · ACS Chemical Neuroscience
  14. Characterization of the brain lipidome associated with frontotemporal lobar degeneration MAPT P301S mutation
    Almudena Maroto Juanes, Thomas Vogels, Sascha Koppes-den Hertog, Maarten Loos, Dieter Lütjohann, Martin A. Giera, Rik van der Kant · 2025 · Journal of Lipid Research
  15. Decreased levels of phosphorylated synuclein in plasma are correlated with poststroke cognitive impairment
    Yi Wang, Yuning Li, Yakun Gu, Wei Ma, Yuying Guan, Mengyuan Guo, Qianqian Shao, Xunming Ji, Jia Liu · 2024 · Neural Regeneration Research
  16. Lower prevalence of metabolic syndrome and its components in the prediagnostic phase of Parkinson’s disease
    Hila Avisar, Uri Greenbaum, Ruth Djaldetti, Boaz Lerner · 2025 · npj Parkinson s Disease
  17. Concentration‐dependent mutational scanning probes the cellular folding landscape of α‐synuclein in yeast
    Daeun Noh, Robert W. Newberry · 2026 · Protein Science
  18. Comprehensive lipidomics reveal Rotenone exposure induces redox-driven lipid droplet accumulation, systemic lipidome perturbation and differential metabolic prioritization linked to Parkinson’s disease
    Ashutosh Tiwari, Priya Rathor, Rajendra P. Patel, Pawan Kumar Jha, Nicholas Birse, Ratnasekhar Ch · 2026 · NeuroToxicology
  19. Spatial lipidomics identifies α-synuclein-induced lipid changes in an AAV-induced Parkinsonian mouse model
    Yachao He, Ibrahim Kaya, Xiaoqun Zhang, Anna Nilsson, Li Cao, Per E. Andrén, Per Svenningsson · 2026 · Neurobiology of Disease
  20. Combined toxicity prediction of deoxynivalenol and fumonisin B1 by physiologically based toxicokinetic modelling and in vitro toxicity mechanism study on astrocyte-like C6 cells
    Xinlu Wang, Liuqing Wang, Haoran Wu, Bingxu Yao, Meng Wang · 2026 · Journal of Hazardous Materials
  21. Lipid membrane remodeling by myristic acid treatment reverses Parkinson’s disease α-synuclein phenotypes in patient neurons
    Julián Ávila-Pacheco, Gleidia Sauli, Luis Fonseca‐Ornelas, Haley Cirka, Deepa Kumari, Morgan Hazo, Sarah Jeanfavre, Pedro H. Vendramini, Christina Muratore, Clary B. Clish et al. · 2026 · npj Metabolic Health and Disease
  22. OLHA (N-oleoylhistamine) modulates activity of mouse brain histaminergic neurons
    Olga A. Sergeeva, Karolina Mazur, David Reiner‐Link, Kiril Lutsenko, Helmut L. Haas, Mercedes Alfonso‐Prieto, Holger Stark · 2022 · Neuropharmacology
  23. Pathophysiology and Management Approaches for Parkinson’s Disease
    Sabiya Samim Khan, Padmashri Naren, Poojitha Pinjala, Sai Nikhil Uppala, Shashi Bala Singh, Dharmendra Kumar Khatri · 2023 · Springer eBooks
  24. Fatty acids as potential biomarkers of stearoyl-CoA desaturase inhibition: Variation in healthy subjects and Parkinson's disease patients
    Pepijn P.N.M. Eijsvogel, Andriy A. Gorbenko, Daniel F. Tardiff, Michelle Skupien, Ken Rhodes, Robert H. Scannevin, Yalçin Yavuz, Emilie M.J. van Brummelen, Brigitte Robertson, Philip H. C. Kremer et al. · 2025 · Biomarkers in Neuropsychiatry
  25. Metabolomics and biochemical alterations caused by pleiotrophin in the 6-hydroxydopamine mouse model of Parkinson’s disease
    Esther Gramage, Jorge Sáiz, Rosalía Fernández‐Calle, Yasmina B. Martín, María Uribarri, Marcel Ferrer‐Alcón, Coral Barbas, Gonzalo Herradón · 2022 · Scientific Reports
  26. A small molecule screen for paqr-2 suppressors identifies Tyloxapol as a membrane fluidizer for C. elegans and mammalian cells
    Mario Ruiz, Emma Svensk, Elinor Einarsson, Erik Podda Grahn, Marc Pilon · 2022 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  27. α-Synuclein Aggregates and Parkinson's disease
    Isadora Cucolo Oliveira, Tárik Abdalla dos Santos, Ian Vilas Boas Covizzi, Thatiana Scalon, João Renato Villas Bôas, Frans Eberth Costa Andrade, Alba Regina de Abreu Lima, Sheila Adami Vayego, Uderlei Doniseti Silveira Covizzi · 2024 · Seven Editora eBooks
  28. Condensate-Driven Triglyceride Depletion Links α-Synuclein to Mitochondrial Dysfunction
    Tao Zhang, María Eugenia Goya, Alejandro Herrón-Bedoya, Jorien C. van der Weerd, Dikaia Tsagkari, Suzanne Couzijn, Lale Güngördü, Renée I. Seinstra, Margaretha Rebecca Heiner-Fokkema, Ming Chang et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  29. Loss of Nuclear TDP-43 Impairs Lipid Metabolism in Microglia-Like Cells
    Khushbu Kabra, Dallin Dressman, Ryan Talcoff, Maedot Yidenk, Olivia M. Rifai, Benjamin N. Hoover, Neil A. Shneider, Wassim Elyaman, Estela Área-Gómez, Elizabeth M. Bradshaw · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  30. Correlation between α-synuclein and fatty acid composition in jejunum of rotenone-treated mice is dependent on acyl chain length
    Dominika Hajdúchová, Roman Holič, Peter Gajdoš, Milan Čertí­k, Erika Halášová, Renata Péčová, Michal Pokusa · 2022 · General Physiology and Biophysics
  31. Cellular fibronectin exacerbates α-synuclein aggregation via integrin alpha4beta1 mediated PARP1 and SCD elevation
    Zifeng Huang, Hui Zhong, Yiyu Lu, Ruoyang Yu, Muwei Zhang, Jialing Zheng, Bin Xiao, Zhidong Zhou, Yinghua Yu, Chao Deng et al. · 2025 · Neurotherapeutics
  32. Elevation of Stearoyl‐Coenzyme A Desaturase and Monounsaturated Fatty Acids in Parkinson's Disease Serum
    Finula I. Isik, Russell Pickford, Michelle Chua, Simon J. G. Lewis, Nicolas L. Dzamko, Woojin Scott Kim · 2026 · Movement Disorders
  33. Multi-omics reveal phosphatidic acid phosphatases modify Niemann-Pick type C disease severity
    Andrew B. Munkacsi, Gabriella E. Conway, Keri Multerer, Michael D. Jackson, Lauren S. Csaki, Tamayanthi Rajakumar, Jeffrey P. Sheridan, Eliatan Niktab, Wuh‐Liang Hwu, Yin‐Hsiu Chien et al. · 2026 · iScience
  34. Membrane Fluidity Regulation: From C. elegans to mammalian cells
    Ranjan Devkota · 2020 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  35. Diagnostics of Parkinson’s disease by positron-emission tomography with 18F-DOPA: new approach based on smart clustering
    Ksenia O. Tutsenko, A A Horoshavina, V A Abramov, Карлова Елена Анатольевна, Michael G. Sadovsky · 2020 · Journal of Physics Conference Series
  36. Unsaturated fatty acids profiling in live C. elegans using real-time NMR spectroscopy
    Bruno Hernández Cravero, Gastón Prez, Verónica A. Lombardo, Andrés Binolfi, Diego de Mendoza · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Lipidomics Reveals Glycerophospholipid Metabolism Dysregulation in the Corpus Striatum of Mice Treated with Cefepime
    Xiaocong Liu, Xiaojie Wang, Qingfan Wei, Xiaowei Yang, Jiamei Zhang, Rui Xu, Haoluo Zhang, Shaomin Wang, Xuemei Wan, Linhong Jiang et al. · 2021 · Research Square
  38. Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein
    Charlotte F. Brzozowski, Baraa A. Hijaz, Vijay Singh, Nolwazi Z. Gcwensa, Kaela Kelly, Edward S. Boyden, Andrew B. West, Deblina Sarkar, Laura A. Volpicelli‐Daley · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Transmembrane helices mediate the formation of a stable ternary complex of cyt b 5 reductase, cyt b 5 , and SCD1
    Jiemin Shen, Gang Wu, Ah‐Lim Tsai, Ming Zhou · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Profiling Membrane Lipids in C. elegans Models of Parkinson’s Disease
    Ketaki A. Mahurkar · 2020
  41. Serum phosphorylated α-synuclein: A potential biomarker of poststroke cognitive impairment
    Yi Wang, Yuning Li, Yakun Gu, Wei Ma, Yuying Guan, Mengyuan Guo, Qianqian Shao, Xunming Ji, Jia Liu · 2023 · Research Square
  42. Seeing the Action of Lipid Droplets in Aging and Longevity
    Bo Tao, Hongyuan Yang, Rong Fan · 2023 · GEN Biotechnology
  43. Lipid metabolism in neurodegenerative diseases
    Jeroen F. J. Bogie, Jeroen Guns, Sam Vanherle · 2023 · Elsevier eBooks
  44. The role of polyunsaturated fatty acids: The possibility of diet intervention in Parkinson's disease
    Haoan Tang, Shaojia Chen, Hongjun Liu, Xu Chen · 2023 · MEDS Public Health and Preventive Medicine
  45. Genetic Associations of Lipid-Lowering Drugs and Parkinson’s Disease: A Mendelian Randomization Study
    Lin Shen, Yifan Yang, Yi Li, Hok Leong Chin, Helen Ye Rim Huang, Bernard M.Y. Cheung, Gary Tse, Oscar Hou In Chou, Jiandong Zhou · 2024 · medRxiv
  46. Age-related energetic reprogramming in glial cells: possible correlations with Parkinson’s disease
    Boling Chu, Hongling Xiang, Han Wang, Yu-Ting Lin, Rui Li, Jing Rong Hu, Hao Qian · 2024 · Ageing and Neurodegenerative Diseases
  47. Cellular Fibronectin Exacerbates Α-Synuclein Aggregation via Integrin Alpha4beta1 Mediated PARP1 and SCD Elevation
    Zifeng Huang, Muwei Zhang, Hui Zhong, Jialing Zheng, Ruoyang Yu, Bin Xiao, Zhidong Zhou, Yinghua Yu, Chao Deng, Kunlin Jin et al. · 2024 · SSRN Electronic Journal
  48. A Brief Review on Caenorhabditis elegans Role in Modelling Neurodegenerative Disease
    Himangi Vig, Priyanka Shukla, Anamika Mishra, Ayushi Pal, Ankita Wal · 2024 · Central Nervous System Agents in Medicinal Chemistry
  49. The combination of optogenetic-induced protein aggregation and proximity biotinylation assays strongly implicates endolysosomal proteins in the early stages of α-synuclein aggregation
    Maxime Teixeira, Razan Sheta, Dylan Musiol, Vetso Ranjakasoa, Jérémy Loehr, Jean‐Philippe Lambert, Abid Oueslati · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  50. Mass Spectrometry-Based Methods in CNS Drug Discovery
    Gonzalo Blasco, Rudy Schreiber, Daan van Kruining · 2024 · Springer eBooks
  51. Acute lipid droplet accumulation induced by the inhibition of the phospholipase DDHD2 does not affect the level, solubility, or phosphoserine-129 status of α-synuclein
    Magdalena M. Bolsinger, Tim E. Moors, Lisa Brontesi, Silke Nuber, Ulf Dettmer, Nagendran Ramalingam · 2025 · Metabolic Brain Disease
  52. Stearoyl–coenzyme A desaturase enhances cell survival in human uterine leiomyoma
    Allison S. Komorowski, John Sayler Coon, Melania Lidia Anton, Azna Zuberi, Olivia Sotos, Serdar Ekrem Bulun, Ping Yin · 2025 · F&S Science
  53. Profiling X chromosome genes expression relevant to sex dimorphism in stroke: insights from transcriptomics landscape analysis
    Xiude Qin, Yuerong Li, Qian Cai, Jiaye Liu, Zhao-Hui Dang, Liling Li, Jia‐Wei Min, Shaohua Qi, Fan Bu · 2025 · Frontiers in Genetics
  54. Perilipin 4 Repetitive Region Forms Amyloid Fibrils Promoted by a Genetic Expansion Found in Myopathy Patients
    Charbel Choufani, Nicolas Fuggetta, Cyril Moulin, Bayane Sabbagh, Céline Franckhauser, Sébastien Lyonnais, Ana‐Andreea Arteni, Sylvie Rouquier, Tinkara Perme, Sophie Pagnotta et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  55. A guide to selecting high-performing antibodies for Stearoyl-CoA desaturase (SCD1) (UniProt ID: O00767) for use in western blot, immunoprecipitation, and immunofluorescence
    Vera Ruíz Moleón, Charles Alende, Maryam Fotouhi, Sara González Bolívar, Riham Ayoubi, Carl Laflamme, NeuroSGC/YCharOS/EDDU collaborative group · 2025 · F1000Research
  56. In vivo inhibition of stearoyl-CoA desaturase modulates the hippocampal fatty acid profile and restores density of dendritic spines in the aggressive 5xFAD model of Alzheimer’s disease
    Marta Turri, Myriam Aubin, Anne Aumont, Annick Vachon, Jessica Avila Lopez, Marian Mayhue, Mélanie Plourde, Karl J. L. Fernandes · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  57. NPAS2 attenuates VSMC phenotypic switching in ascending thoracic aortic aneurysm via LPCAT3/PC-PUFA2S-mediated ferroptosis
    Wenfeng Lin, Jiaqi Xiong, Yuhan Yan, Jinhui Bian, Zhen Zhang, Xinyang Xu, Yifei Diao, Xiaoxia Lan, Yu Zhong, Haibin Ji et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Integrative lipidomics of brain and plasma uncovers sex-specific metabolic signatures in Parkinson’s disease
    Unnati Agrawal, Priya Nataraj, Aakash Chandramouli, Syam Krishnan, Siddhesh S. Kamat, Madhusoodanan Urulangodi, Poonam Singh Thakur · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  59. Additional file 3 of Uncovering the ferroptosis related mechanism of laduviglusib in the cell-type-specific targets of the striatum in Huntington’s disease
    Liu, Mei, Zhao, Jinlan, Xue, Chengcheng, Yang, Jun, Ying, Li · 2024 · Figshare
  60. Additional file 6 of Uncovering the ferroptosis related mechanism of laduviglusib in the cell-type-specific targets of the striatum in Huntington’s disease
    Liu, Mei, Zhao, Jinlan, Xue, Chengcheng, Yang, Jun, Ying, Li · 2024 · Figshare
  61. Additional file 1 of APOE deficiency impacts neural differentiation and cholesterol biosynthesis in human iPSC-derived cerebral organoids
    Zhao, Jing, Tadafumi C. Ikezu, Wenyan Lü, Jesse R. Macyczko, Yonghe Li, Laura J. Lewis‐Tuffin, Yuka A. Martens, Yingxue Ren, Yiyang Zhu, Yan W. Asmann et al. · 2023 · Figshare
  62. Additional file 9 of Uncovering the ferroptosis related mechanism of laduviglusib in the cell-type-specific targets of the striatum in Huntington’s disease
    Liu, Mei, Zhao, Jinlan, Xue, Chengcheng, Yang, Jun, Ying, Li · 2024 · Figshare
  63. Additional file 1 of Isotope-reinforced polyunsaturated fatty acids improve Parkinson’s disease-like phenotype in rats overexpressing α-synuclein
    Beal, M. Flint, Jayandra Chiluwal, Noel Ylagan Calingasan, Ginger L. Milne, Mikhail S. Shchepinov, Vı́ctor Tapias · 2020 · Figshare
  64. Additional file 1 of Increased unsaturated lipids underlie lipid peroxidation in synucleinopathy brain
    Fu, YuHong, He, Ying, Katherine Phan, Surabhi Bhatia, Russell Pickford, Wu, Ping, Dzamko, Nicolas, Glenda M. Halliday, Woojin Scott Kim · 2022 · Figshare
  65. Additional file 1 of Uncovering the ferroptosis related mechanism of laduviglusib in the cell-type-specific targets of the striatum in Huntington’s disease
    Liu, Mei, Zhao, Jinlan, Xue, Chengcheng, Yang, Jun, Ying, Li · 2024 · Figshare
  66. Additional file 2 of Uncovering the ferroptosis related mechanism of laduviglusib in the cell-type-specific targets of the striatum in Huntington’s disease
    Liu, Mei, Zhao, Jinlan, Xue, Chengcheng, Yang, Jun, Ying, Li · 2024 · Figshare
  67. Additional file 4 of Uncovering the ferroptosis related mechanism of laduviglusib in the cell-type-specific targets of the striatum in Huntington’s disease
    Liu, Mei, Zhao, Jinlan, Xue, Chengcheng, Yang, Jun, Ying, Li · 2024 · Figshare
  68. Additional file 11 of Uncovering the ferroptosis related mechanism of laduviglusib in the cell-type-specific targets of the striatum in Huntington’s disease
    Liu, Mei, Zhao, Jinlan, Xue, Chengcheng, Yang, Jun, Ying, Li · 2024 · Figshare
  69. Additional file 5 of Uncovering the ferroptosis related mechanism of laduviglusib in the cell-type-specific targets of the striatum in Huntington’s disease
    Liu, Mei, Zhao, Jinlan, Xue, Chengcheng, Yang, Jun, Ying, Li · 2024 · Figshare
  70. Additional file 7 of Uncovering the ferroptosis related mechanism of laduviglusib in the cell-type-specific targets of the striatum in Huntington’s disease
    Liu, Mei, Zhao, Jinlan, Xue, Chengcheng, Yang, Jun, Ying, Li · 2024 · Figshare
  71. Additional file 12 of Uncovering the ferroptosis related mechanism of laduviglusib in the cell-type-specific targets of the striatum in Huntington’s disease
    Liu, Mei, Zhao, Jinlan, Xue, Chengcheng, Yang, Jun, Ying, Li · 2024 · Figshare
  72. Additional file 8 of Uncovering the ferroptosis related mechanism of laduviglusib in the cell-type-specific targets of the striatum in Huntington’s disease
    Liu, Mei, Zhao, Jinlan, Xue, Chengcheng, Yang, Jun, Ying, Li · 2024 · Figshare
  73. Additional file 10 of Uncovering the ferroptosis related mechanism of laduviglusib in the cell-type-specific targets of the striatum in Huntington’s disease
    Liu, Mei, Zhao, Jinlan, Xue, Chengcheng, Yang, Jun, Ying, Li · 2024 · Figshare
  74. Additional file 1 of Association of serum oleic acid level with depression in American adults: a cross-sectional study
    Jiahui Yin, Li, Siyuan, Li, Jinling, Rongpeng Gong, Jia, Zhixia, Liu, Junjun, Jin, Zhi, Yang, Jiguo, Liu, Yuanxiang · 2023 · Figshare
  75. SREBP1-driven SCD1 protects retinal pigment epithelium from oxidative damage by activating the NRF2/GPX4 axis
    Xingyu Yang, Weichen Xu, Hang Xie, Xiaoyu Guo, Feiyan Zhu, Yiqiao Xing, Changzheng Chen · 2026 · Experimental Eye Research
  76. Membrane-associated intrinsically disordered regions: dual roles in binding and membrane protein function
    Léa Poskin, Hugo Bâlon, Tanguy Leyder, Catherine Michaux, Julien Mignon · 2026 · Critical Insights in Biophysics
  77. From mice to clinical relevance: humanizing neuroscience with human-based model systems
    Aniella Bak, Karen M. J. van Loo, Deborah Kronenberg‐Versteeg, Henner Koch · 2026 · Frontiers in Cellular Neuroscience
  78. Causal relationships between plasma lipidomics, trace elements, cerebrospinal fluid metabolites, and Parkinson's disease using Mendelian randomization
    Mengqi Wang, Mengshuang Huang, ZhaoMing Chen, Shengjie Gou, Chao Ma, Linglong Xiao · 2026 · Brain Research Bulletin
  79. Étude de la propagation prion-like de l'alpha-synucléine dans des réseaux de neurones reconstruits
    Josquin Courte · 2019 · theses.fr (ABES)
  80. Study of the interactions between the nervous system and the gut in Parkinson’s disease using Drosophila
    Xiaojing Yue · 2022 · theses.fr (ABES)
  81. Etude des besoins en stérols des souches de levures œnologiques (Saccharomyces Cerevisiae)
    Giovana Girardi Piva · 2022 · theses.fr (ABES)
  82. The Emerging Parkinson's Disease Oxylipin‐Ome
    Julia C. Kelliher, Saranna Fanning · 2026 · Advanced Science
  83. Mutational Scanning of α-Synuclein using a Clickable Protein Tag Reveals Determinants of Membrane-Induced Aggregation
    Daeun Noh, Robert W. Newberry · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  84. Systemic ELOVL6 activity predicts survival and represents a modifiable target of ALS
    Andrés Jiménez-Zúñiga, Gorka Fernández‐Eulate, José Ignacio Ruiz-Sanz, Jose Luis Zúñiga-Elizari, Maddi Garciandia-Arcelus, Javier Riancho, Rubén Jara Rubio, Ahmad Al Khleifat, Mónica Zufiría, Sonia Alonso‐Martín et al. · 2026 · medRxiv
  85. Astrocytic ACSBG1 depletion improves lipid-cytokine signaling and attenuates α-Synuclein pathology in a Parkinson’s disease mouse model
    Young Doo Kim, Bhupesh Vaidya, Jiyoen Kim, Sara Bitar, Femil Joseph Shajan, Ajay Kumar Verma, Hari Krishna Yalamanchili, Shubham Singh, Huda Yahya Zoghbi · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  86. Deconvolving the structural heterogeneity of alpha-Synuclein in vitro and in situ
    Liliana Malinovska, Alexandra Malinovska, Yuehan Feng, Lynn Verbeke, Pratibha Kumari, José D. Camino, Valentina Cappelletti, Sonja Kroschwald, Elisa Dultz, Meltem Tatlı et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  87. Neuronal VPS13A depletion links diacylglycerol PKC signaling and synaptic spines
    Gisela Besa-Selva, Esther García-García, Alba Ramón-Lainez, Geòrgia Escaramís, Pol Garcia‐Segura, Cristina Malagelada, Eulàlia Martı́, Jordi Alberch, Mercè Masana, Manuel José Rodríguez · 2026 · BMC Biology
  88. Chronic α-Synuclein Over-Expression and Ceruloplasmin Challenge Promote Distinct Iron and Redox Responses in M17 Cells
    Masoumeh Pourhadi, Bedri Ranxhi, Seth P Sukaria, Fatimah H Hussein, Sokol V. Todi, Peter A. LeWitt, Wei‐Ling Tsou · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  89. Unlocking Parkinson’s disease: harnessing the untapped potential of fatty acid metabolism in disease pathogenesis
    Rong Hu, Yaru Song, Ting Liu, Xinyu He, Yi-Yong Qiu, Fanjing Zhong, Xiao Huang, J.J. Huang, Zhigang Jiao · 2026 · Frontiers in Immunology
  90. Age-dependent changes in lipid droplet distribution and vascularization in naked mole rat vs. mouse hippocampus
    Liv S Krogstad, Markus Augustin Teppen, Harald S Mjønes, Jonathan Richard Brewer, Thomas J. Park, Samuel J. Geiseler, Cecilie Morland · 2026 · GeroScience
  91. Condensate-driven triglyceride reduction links α-synuclein to mitochondrial dysfunction
    Tao Zhang, Alejandro Herrón-Bedoya, María Eugenia Goya, Jorien C. van der Weerd, Dikaia Tsagkari, Suzanne Couzijn, Lale Güngördü, Anna P. Ainslie, Renée I. Seinstra, Margaretha Rebecca Heiner-Fokkema et al. · 2026 · EMBO Reports
  92. Cellular and systemic modifiers of alpha-synuclein proteostasis
    Suzanne Couzijn, Anna P. Ainslie, Alejandro Herrón-Bedoya, Ellen A. A. Nollen · 2026 · Philosophical Transactions of the Royal Society B Biological Sciences
  93. Longitudinal untargeted metabolomics of cognitive impairment in Parkinson's disease
    Yuyuan Lin, Yu Yu, Keren Zhang, Irish Del Rosario, Aline Duarte Folle, Elizabeth Rose Mayeda, Dean P. Jones, Douglas I. Walker, Jeff M. Bronstein, Adrienne M. Keener et al. · 2026 · Alzheimer s & Dementia
  94. α-Synuclein pathology induces conserved lipid acyl-chain remodeling across mouse brain and human dopaminergic neurons
    Elisabeth Dinter, Éva M. Szegő, Hella Luksch, Lennart Höfs, Björn H. Falkenburger · 2026 · Research Square
  95. From dosage alteration to amplification strategies: mechanistically defined alpha-synuclein mouse models for Parkinson’s disease therapy development
    Silke Nuber, Saranna Fanning, Ulf Dettmer · 2026 · Acta Neuropathologica
  96. Metabolic endotyping for mechanism-informed Alzheimer’s and Parkinson’s disease trials
    José A. Santiago, Olivier Rascol, Tom Foltynie, Wassilios G. Meissner, Judith A. Potashkin, Jean C. Gutierrez-Silva, Mohammad Nafeli Shahrestani, Yusen Wu, Tatjana Rundek, Ihtsham Ul Haq · 2026 · Med
  97. APOE genotypes differentially remodel the astrocytic lipid droplet proteome to shape lipid droplet dynamics
    Cuní-López, Carla, Root, Jessica T., Hao, Ying, Blomberg, Niek, Koppes-den Hertog, Sascha J., Sacks, Dylan, Trujillo, Amber E., Ghirlando, Rodolfo, Kowal, Isabelle, Epstein, Jacob et al. · 2026 · Nature Communications